An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.

Journal: Cell

Published: 2021-06-24

DOI: 10.1016/j.cell.2021.05.032

Affiliations: 17

Authors: 37

Go to article
Institutions Share
Osaka University, Japan 0.81
Kobe City Medical Center General Hospital, Japan 0.08
HuLA immune, Inc., Japan 0.08
Osaka Minami Medical Center, Japan 0.03